Replies to post #4895 on AEterna Zentaris Inc. (AEZS)

[~ Blue ~]

AEZS~ $45 million cash, all series C warrants exercised and only 183 million outstanding shares

Enough cash to last at least 18 months that is beyond phase 3 results of ZopTec and 6 months before commercialization of Macrilen.
Excellent news!

http://www.aezsinc.com/en/page.php?p=60&q=684

[~ Blue ~]

AEZS~ https://clinicaltrials.gov/ct2/show/NCT01767155?term=AEZS-108+endometrial+cancer&rank=1